Restatement Of Condensed Consolidated Financial Statements (Condensed Consolidated Statements Of Cash Flow) (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities of continuing operations
Net income / (loss)	$ (33,465)	$ (5,367)
Adjustments to reconcile net income / (loss) to net cash provided by operating activities:
Depreciation and amortization	9,843
Deferred income taxes	(3,809)
Unrealized foreign exchange (gains) / losses	(20,196)
Stock options fair value expense	1,589
Equity (income) / loss in affiliates	0
Gain on fair value remeasurement of previously held equity interest	0
Other non cash items	1,042
Changes in operating assets and liabilities:
Accounts receivable	201,151
Inventories	(19,190)
Prepaid expenses and other current assets	(6,686)
Trade accounts payable	(69,031)
Other accrued liabilities and payables	(52,929)
Cash flows from investing activities of continuing operations
Purchase of fixed assets	(4,781)
Purchase of intangibles	0
Purchase of trademarks	0
Acquisitions of subsidiaries, net of cash acquired	0
Cash flows from financing activities of continuing operations
Borrowing on banks loans, overdraft facility and other borrowings	14,987
Payment of bank loans, overdraft facility and other borrowings	(37,214)
Decrease in short term capital leases payable	(10)
Options exercised	0
Currency effect on brought forward cash balances	(895)
Net increase in cash	44,270
Cash and cash equivalents at beginning of period	94,410
Cash and cash equivalents at end of period	138,680
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries	0
As Reported [Member]
Cash flows from operating activities of continuing operations
Net income / (loss)		4,135
Adjustments to reconcile net income / (loss) to net cash provided by operating activities:
Depreciation and amortization		10,765
Deferred income taxes		(4,216)
Unrealized foreign exchange (gains) / losses		(50,732)
Stock options fair value expense		1,336
Equity (income) / loss in affiliates		8,814
Gain on fair value remeasurement of previously held equity interest		(6,397)
Other non cash items		2,803
Changes in operating assets and liabilities:
Accounts receivable		263,804
Inventories		(2,353)
Prepaid expenses and other current assets		(12,327)
Trade accounts payable		(83,383)
Other accrued liabilities and payables		(89,111)
Net cash provided by operating activities from continuing operations		43,138
Cash flows from investing activities of continuing operations
Purchase of fixed assets		(3,181)
Purchase of intangibles		(693)
Purchase of trademarks		(17,473)
Acquisitions of subsidiaries, net of cash acquired		(24,124)
Net cash provided by / (used in) investing activities from continuing operations		(45,471)
Cash flows from financing activities of continuing operations
Borrowing on banks loans, overdraft facility and other borrowings		30,983
Payment of bank loans, overdraft facility and other borrowings		(34,401)
Decrease in short term capital leases payable		(277)
Options exercised		72
Net cash used in financing activities from continuing operations		(3,623)
Currency effect on brought forward cash balances		10,166
Net increase in cash		4,210
Cash and cash equivalents at beginning of period		122,324
Cash and cash equivalents at end of period		126,534
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries		23,175
Supplemental disclosures of cash flow information
Interest paid		44,251
Income tax paid		8,950
Adjustment [Member]
Cash flows from operating activities of continuing operations
Net income / (loss)		(9,502)
Adjustments to reconcile net income / (loss) to net cash provided by operating activities:
Depreciation and amortization		0
Deferred income taxes		(1,455)
Unrealized foreign exchange (gains) / losses		(208)
Stock options fair value expense		0
Equity (income) / loss in affiliates		(868)
Gain on fair value remeasurement of previously held equity interest		0
Other non cash items		(9)
Changes in operating assets and liabilities:
Accounts receivable		11,057
Inventories		(14,680)
Prepaid expenses and other current assets		(1,541)
Trade accounts payable		23,832
Other accrued liabilities and payables		(6,430)
Net cash provided by operating activities from continuing operations		196
Cash flows from investing activities of continuing operations
Purchase of fixed assets		12
Purchase of intangibles		0
Purchase of trademarks		0
Acquisitions of subsidiaries, net of cash acquired		0
Net cash provided by / (used in) investing activities from continuing operations		12
Cash flows from financing activities of continuing operations
Borrowing on banks loans, overdraft facility and other borrowings		0
Payment of bank loans, overdraft facility and other borrowings		0
Decrease in short term capital leases payable		0
Options exercised		0
Net cash used in financing activities from continuing operations		0
Currency effect on brought forward cash balances		0
Net increase in cash		208
Cash and cash equivalents at beginning of period		(208)
Cash and cash equivalents at end of period		0
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries		0
Supplemental disclosures of cash flow information
Interest paid		0
Income tax paid		0
Restated [Member]
Cash flows from operating activities of continuing operations
Net income / (loss)		(5,367)
Adjustments to reconcile net income / (loss) to net cash provided by operating activities:
Depreciation and amortization		10,765
Deferred income taxes		(5,671)
Unrealized foreign exchange (gains) / losses		(50,940)
Stock options fair value expense		1,336
Equity (income) / loss in affiliates		7,946
Gain on fair value remeasurement of previously held equity interest		(6,397)
Other non cash items		2,794
Changes in operating assets and liabilities:
Accounts receivable		274,861
Inventories		(17,033)
Prepaid expenses and other current assets		(13,868)
Trade accounts payable		(59,551)
Other accrued liabilities and payables		(95,541)
Net cash provided by operating activities from continuing operations		43,334
Cash flows from investing activities of continuing operations
Purchase of fixed assets		(3,169)
Purchase of intangibles		(693)
Purchase of trademarks		(17,473)
Acquisitions of subsidiaries, net of cash acquired		(24,124)
Net cash provided by / (used in) investing activities from continuing operations		(45,459)
Cash flows from financing activities of continuing operations
Borrowing on banks loans, overdraft facility and other borrowings		30,983
Payment of bank loans, overdraft facility and other borrowings		(34,401)
Decrease in short term capital leases payable		(277)
Options exercised		72
Net cash used in financing activities from continuing operations		(3,623)
Currency effect on brought forward cash balances		10,166
Net increase in cash		4,418
Cash and cash equivalents at beginning of period		122,116
Cash and cash equivalents at end of period		126,534
Supplemental Schedule of Non-cash Investing Activities
Common stock issued in connection with investment in subsidiaries		23,175
Supplemental disclosures of cash flow information
Interest paid		44,251
Income tax paid		$ 8,950